Considering that IL-17RA and IL-17RC are specific receptors for IL-17A as well as angiogenic properties of IL-17A, it seems that an increase in the expression of these types of receptors may contribute to tumor progression through VEGF- and CXCR2-dependent angiogenesis along with chronic inflammatory consequences [32]. The gene discussed is CXCR2; the disease is neoplasm.